Skip to main content

MoneyWorks4Me

Lupin submits Press Release

08 Mar 2025 Evaluate

Lupin has submitted a Press Release as regards, launch of Rivaroxaban Tablets USP, 2.5 mg, following the final approval from the U.S. FDA for the Company’s Abbreviated New Drug Application.

The above information is a part of company’s filings submitted to BSE.


Peers
Company Name CMP
Sun Pharma. Inds. 1907.45
Dr. Reddys Labs. 1380.00
Cipla 1402.25
Lupin 2020.00
Zydus Lifesciences 1215.90
View more..